文献速递肿瘤 PET/CT

PET/CT在肺癌放疗前靶区勾画中的进展

Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy.
PubMed 文献 · Semin Nucl Med · 2025-03-09

本综述讨论放疗在肺癌多学科管理中的作用,详述用于分期和治疗计划的形态学与功能影像概念,并强调PET放疗计划的日益重要性,包括AI、放射组学和新型PET配体等方法学进展对靶区定义和治疗结局预测价值的贡献。

要点

  • 放疗是肺癌多模式治疗的基石,常与手术或化疗、酪氨酸激酶抑制剂、免疫检查点抑制剂联合使用。
  • [18F]FDG PET/CT正越来越多地整合到常规临床实践中,提供分子和代谢肿瘤特征信息。
  • PET放疗计划在靶区定义和治疗结局预测方面日益重要,AI、放射组学和新型PET配体等方法学进展有望提高精准性。

核心结论

  • PET/CT在肺癌放疗靶区勾画和预测治疗结局方面日益重要,方法学进展有望改善放疗计划的精准性、疗效和个体化。

研究设计与样本

  • 本综述未报告系统检索范围。

主要发现

  • [18F]FDG PET/CT可提供分子和代谢肿瘤特征,实现精确肿瘤可视化、准确靶区体积勾画和早期治疗反应评估。
  • PET放疗计划对靶区定义有贡献,并对治疗结局具有预测价值。

关键数值与推荐

  • 本文未汇总具体标准或数值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the clinical management of lung cancer, radiotherapy remains a cornerstone of multimodal treatment strategies, often used alongside surgery or in combination with systemic therapies such as chemotherapy, tyrosine kinase inhibitors, and immune checkpoint inhibitors. While conventional imaging modalities like computed tomography (CT) and magnetic resonance imaging (MRI) continue to play a central role in staging, response assessment, and radiotherapy planning, advanced imaging techniques, particularly [18F]FDG PET/CT, are being increasingly integrated into routine clinical practice. These advanced techniques address the limitations of standard imaging by providing insight into molecular and metabolic tumor characteristics, enabling precise tumor visualization, accurate target volume delineation, and early treatment response assessment. This review examines the role of radiotherapy in the multidisciplinary management of lung cancer, detailing current concepts of morphological and functional imaging for staging and treatment planning. It also highlights the growing importance of PET-based radiotherapy planning, emphasizing its contributions to target volume definition and predictive value for treatment outcomes. Recent methodological advances, including the integration of artificial intelligence (AI), radiomics, technical innovations, and novel PET ligands, are discussed, highlighting their potential to improve the precision, efficacy, and personalization of lung cancer radiotherapy planning.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Richlitzki C, Manapov F, Holzgreve A, et al. Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy. Semin Nucl Med. 2025. PMID: 40064578. doi:10.1053/j.semnuclmed.2025.02.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。